Venous thromboembolism: Pathophysiology and clinicat présentation
- Author
- HAINES, Stuart T1
[1] School of Pharmacy, University of Maryland, 100 Penn Street, Room 240H, Baltimore, MD 21201, United States - Conference title
- Evolution in the management of thrombotic disorders: The role of factor Xa inhibition in the continuum of care
- Conference name
- Evolution in the Management of Thrombotic Disorders: The Role of Factor Xa Inhibition in the Continuum of Care. Symposium (Atlanta, GA 2002-12-08)
- Author (monograph)
- HAWKINS, David (Editor)1
[1] The Medical College of Georgia, Mercer University Southern School of Pharmacy, 3001 Mercer University Drive, Atlanta, GA 30341-4155, United States - Source
American journal of health-system pharmacy. 2003, Vol 60, pp 3-5, 3 p ; SUP7 ; ref : 9 ref
- ISSN
- 1079-2082
- Scientific domain
- Pharmacology drugs
- Publisher
- American Society of Health Pharmacists, Bethesda, MD
- Publication country
- United States
- Document type
- Conference Paper
- Language
- English
- Author keyword
- Costs Ecomomics Mortality Pharmacists Protocols Thromboembolism
- Keyword (fr)
- Analyse coût Article synthèse Coût Diagnostic Economie santé Embolie pulmonaire Homme Mortalité Physiopathologie Prévention Recommandation Récidivant Santé publique Thromboembolie Veine profonde Appareil circulatoire pathologie Appareil respiratoire pathologie Vaisseau sanguin pathologie Veine pathologie
- Keyword (en)
- Cost analysis Review Costs Diagnosis Health economy Pulmonary embolism Human Mortality Pathophysiology Prevention Recommendation Recurrent Public health Thromboembolism Deep vein Cardiovascular disease Respiratory disease Vascular disease Venous disease
- Keyword (es)
- Análisis costo Artículo síntesis Coste Diagnóstico Economía salud Embolia pulmonar Hombre Mortalidad Fisiopatología Prevención Recomendación Recidivante Salud pública Tromboembolia Vena profunda Aparato circulatorio patología Aparato respiratorio patología Vaso sanguíneo patología Vena patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11C Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12B Blood and lymphatic vessels / 002B12B06 Miscellaneous
- Discipline
- Cardiology. Circulatory system Pulmonology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 15317707
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1093/ajhp/60.suppl_7.S3 
https://dx.doi.org/10.1093/ajhp/60.suppl_7.S3
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1093\/ajhp\/60.suppl_7.S3\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"Venous thromboembolism: Pathophysiology and clinicat pr\u00e9sentation\";s:9:\"\u0000*\u0000jtitle\";s:42:\"American journal of health-system pharmacy\";s:9:\"\u0000*\u0000stitle\";s:25:\"Am. j. health-syst. pharm\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:1:\"3\";s:8:\"\u0000*\u0000epage\";s:1:\"5\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1079-2082\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"HAINES\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Stuart T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP7\";s:9:\"\u0000*\u0000btitle\";s:110:\"Evolution in the management of thrombotic disorders: The role of factor Xa inhibition in the continuum of care\";s:8:\"\u0000*\u0000title\";s:66:\"Venous thromboembolism: Pathophysiology and clinicat pr\u00e9sentation\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:38:\"American Society of Health Pharmacists\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"3\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1093\/ajhp\/60.suppl_7.S3\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"Venous thromboembolism: Pathophysiology and clinicat pr\u00e9sentation\";s:9:\"\u0000*\u0000jtitle\";s:42:\"American journal of health-system pharmacy\";s:9:\"\u0000*\u0000stitle\";s:25:\"Am. j. health-syst. pharm\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:1:\"3\";s:8:\"\u0000*\u0000epage\";s:1:\"5\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1079-2082\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"HAINES\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Stuart T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP7\";s:9:\"\u0000*\u0000btitle\";s:110:\"Evolution in the management of thrombotic disorders: The role of factor Xa inhibition in the continuum of care\";s:8:\"\u0000*\u0000title\";s:66:\"Venous thromboembolism: Pathophysiology and clinicat pr\u00e9sentation\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:38:\"American Society of Health Pharmacists\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"3\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:26:\"10.1093\/ajhp\/60.suppl_7.S3\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1093\/ajhp\/60.suppl_7.S3\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"Venous thromboembolism: Pathophysiology and clinicat pr\u00e9sentation\";s:9:\"\u0000*\u0000jtitle\";s:42:\"American journal of health-system pharmacy\";s:9:\"\u0000*\u0000stitle\";s:25:\"Am. j. health-syst. pharm\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:1:\"3\";s:8:\"\u0000*\u0000epage\";s:1:\"5\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1079-2082\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"HAINES\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Stuart T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP7\";s:9:\"\u0000*\u0000btitle\";s:110:\"Evolution in the management of thrombotic disorders: The role of factor Xa inhibition in the continuum of care\";s:8:\"\u0000*\u0000title\";s:66:\"Venous thromboembolism: Pathophysiology and clinicat pr\u00e9sentation\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:38:\"American Society of Health Pharmacists\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"3\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1093\/ajhp\/60.suppl_7.S3\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"Venous thromboembolism: Pathophysiology and clinicat pr\u00e9sentation\";s:9:\"\u0000*\u0000jtitle\";s:42:\"American journal of health-system pharmacy\";s:9:\"\u0000*\u0000stitle\";s:25:\"Am. j. health-syst. pharm\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:1:\"3\";s:8:\"\u0000*\u0000epage\";s:1:\"5\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1079-2082\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"HAINES\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Stuart T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP7\";s:9:\"\u0000*\u0000btitle\";s:110:\"Evolution in the management of thrombotic disorders: The role of factor Xa inhibition in the continuum of care\";s:8:\"\u0000*\u0000title\";s:66:\"Venous thromboembolism: Pathophysiology and clinicat pr\u00e9sentation\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:38:\"American Society of Health Pharmacists\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"3\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1093\/ajhp\/60.suppl_7.S3\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"Venous thromboembolism: Pathophysiology and clinicat pr\u00e9sentation\";s:9:\"\u0000*\u0000jtitle\";s:42:\"American journal of health-system pharmacy\";s:9:\"\u0000*\u0000stitle\";s:25:\"Am. j. health-syst. pharm\";s:7:\"\u0000*\u0000date\";s:4:\"2003\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:0:\"\";s:8:\"\u0000*\u0000spage\";s:1:\"3\";s:8:\"\u0000*\u0000epage\";s:1:\"5\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1079-2082\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"HAINES\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Stuart T\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:0:{}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP7\";s:9:\"\u0000*\u0000btitle\";s:110:\"Evolution in the management of thrombotic disorders: The role of factor Xa inhibition in the continuum of care\";s:8:\"\u0000*\u0000title\";s:66:\"Venous thromboembolism: Pathophysiology and clinicat pr\u00e9sentation\";s:8:\"\u0000*\u0000place\";s:12:\"Bethesda, MD\";s:6:\"\u0000*\u0000pub\";s:38:\"American Society of Health Pharmacists\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"3\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
